Kirby Institute, University of New South Wales, Sydney, NSW.
New York University School of Medicine, New York, New York, United States.
Med J Aust. 2019 Nov;211(9):406-411. doi: 10.5694/mja2.50322. Epub 2019 Aug 29.
To estimate rates of HIV infection, chlamydia, gonorrhoea, and infectious syphilis in transgender men and women in Australia; to compare these rates with those for cisgender people.
Cross-sectional, comparative analysis of de-identified health data.
SETTING, PARTICIPANTS: We analysed data for 1260 transgender people (404 men, 492 women, 364 unrecorded gender), 78 108 cisgender gay and bisexual men, and 309 740 cisgender heterosexual people who attended 46 sexual health clinics across Australia during 2010-2017.
First-visit test positivity for sexually transmitted infections (STIs), stratified by patient group and year; demographic and behavioural factors associated with having STIs.
14 of 233 transgender men (6.0%) and 34 of 326 transgender women (10%) tested during first clinic visits were chlamydia-positive; nine transgender men (4%) and 28 transgender women (8.6%) were gonorrhoea-positive. One of 210 tested transgender men (0.5%) and ten of 324 tested transgender women (3.1%) were diagnosed with infectious syphilis; 14 transgender men (3.5%) and 28 transgender women (5.7%) were HIV-positive at their first visit. The only significant change in prevalence of an STI among transgender patients during the study period was the increased rate of gonorrhoea among transgender women (from 3.1% to 9.8%). Compared with cisgender gay and bisexual men, transgender men were less likely (adjusted odds ratio [aOR], 0.46; 95% CI, 0.29-0.71; P = 0.001) and transgender women as likely (aOR, 0.98; 95% CI, 0.73-1.32; P = 0.92) to be diagnosed with a bacterial STI; compared with heterosexual patients, transgender men were as likely (aOR, 0.72; 95% CI, 0.46-1.13; P = 0.16) and transgender women more likely (aOR, 1.56; 95% CI, 1.16-2.10; P = 0.003) to receive a first-visit bacterial STI diagnosis.
The epidemiology of STIs in transgender people attending Australian sexual health clinics differs from that of cisgender patients. Gender details must be captured by health data systems to facilitate appropriate delivery of sexual health care.
估计澳大利亚跨性别男性和女性中的艾滋病毒感染、衣原体、淋病和感染性梅毒的感染率;将这些比率与顺性别者的比率进行比较。
对去识别健康数据的横断面、比较分析。
地点、参与者:我们分析了 2010-2017 年间在澳大利亚 46 家性健康诊所就诊的 1260 名跨性别者(404 名男性,492 名女性,364 名未记录性别)、78048 名顺性别男同性恋和双性恋者以及 309740 名顺性别异性恋者的资料。
首次就诊时性传播感染(STI)的阳性检出率,按患者群体和年份分层;与 STI 相关的人口统计学和行为因素。
在首次就诊时,233 名跨性别男性中有 14 名(6.0%)和 326 名跨性别女性中有 34 名(10%)的衣原体呈阳性;9 名跨性别男性(4%)和 28 名跨性别女性(8.6%)淋病呈阳性。210 名接受检测的跨性别男性中有 1 名(0.5%)和 324 名接受检测的跨性别女性中有 10 名(3.1%)被诊断为感染性梅毒;14 名跨性别男性(3.5%)和 324 名接受检测的跨性别女性中有 28 名(5.7%)在首次就诊时 HIV 呈阳性。在研究期间,跨性别患者中唯一显著变化的 STI 流行率是,跨性别女性的淋病发病率增加(从 3.1%增加到 9.8%)。与男同性恋和双性恋顺性别者相比,跨性别男性(调整后的优势比 [aOR],0.46;95%CI,0.29-0.71;P=0.001)较少被诊断为细菌 STI,而跨性别女性(aOR,0.98;95%CI,0.73-1.32;P=0.92)的可能性与顺性别者相似;与异性恋患者相比,跨性别男性(aOR,0.72;95%CI,0.46-1.13;P=0.16)的可能性与顺性别者相似,而跨性别女性(aOR,1.56;95%CI,1.16-2.10;P=0.003)更有可能首次被诊断为细菌 STI。
在澳大利亚性健康诊所就诊的跨性别者的性传播感染流行病学与顺性别者不同。健康数据系统必须捕获性别详细信息,以促进提供适当的性健康护理。